Catalyst Pharmaceuticals Inc (CPRX) stock news · rev $589.0M
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
This CPRX news page leads with what Catalyst Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for CPRX yet. We will not pad this page with generic market recap.
Latest reported CPRX revenue for 2025-12-31 was $589.0M. Net income was $214.3M. Revenue was up 19.8% from 2024-12-31 to 2025-12-31. CPRX currently screens at market cap $3.84B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CPRX stock page; for the tape open the quote page.
CPRX stock news FAQ
What are CPRX's latest revenue and net income?
Latest cached Catalyst Pharmaceuticals Inc (CPRX) revenue for Dec 31, 2025 was $589.0M. Net income was $214.3M. Statements: https://lician.com/financials/cprx
How did CPRX revenue change from the prior cached period?
Cached Catalyst Pharmaceuticals Inc (CPRX) revenue was up 19.8% from $491.7M (Dec 31, 2024) to $589.0M (Dec 31, 2025). Statements: https://lician.com/financials/cprx
What is CPRX's market cap?
Catalyst Pharmaceuticals Inc (CPRX) market cap is $3.84B on the latest cached fundamentals snapshot.
What kind of company is CPRX?
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Where is CPRX stock news listed?
Cached stock news for Catalyst Pharmaceuticals Inc (CPRX) is listed at https://lician.com/news/cprx. Filings: https://lician.com/sec/cprx
Not investment advice.